Business Wire

GSMA Announces New Keynote Speakers for 2018 Mobile World Congress

Del

The GSMA today announced nearly a dozen new keynote speakers for the upcoming Mobile World Congress 2018, as well as updates on exhibitors, sponsors, partners and programmes. Mobile World Congress will be held 26 February – 1 March 2018 at Fira Gran Via in Barcelona, with events also taking place at Fira Montjuïc and La Farga L’Hospitalet.

“We have an amazing show lined up for 2018, across the conference, the exhibition and the many programmes and events that comprise Mobile World Congress,” said Michael O’Hara, Chief Marketing Officer, GSMA. “Attendees will have the opportunity to experience many new elements this year, most notably the hospitality and networking areas in the new South Village at Fira Gran Via. We’re looking forward to showcasing how mobile is creating a better future for all.”

New Keynote Speakers Confirmed

The GSMA announced nearly a dozen new keynote speakers for the Mobile World Congress conference programme, representing organisations spanning the broad mobile ecosystem, as well as government and the development community. Recently confirmed keynote speakers include:

  • Brigitte Baumann, Founder and Chief Investment Officer, Go Beyond Early Stage Investing
  • Brian Behlendorf, Executive Director, Hyperledger
  • Ricardo Antonio Rosselló Nevares, Governor, Puerto Rico
  • Marie Ehrling, Chair of the Board, Telia Group and Chairwoman, Securitas
  • Alastair MacLeod, CEO, Teralytics
  • Kathy Calvin, President and CEO, United Nations Foundation
  • Ajit Pai, Chairman, United States Federal Communications Commission
  • Dr. Jim Yong Kim, President, World Bank

New for the 2018 programme, the Women4Tech keynote will be held on Thursday, 1 March, featuring speakers including Emma McGuigan, Group Technology Officer at Accenture, Berit Svendson, CEO of Telenor Norway and Susana Balbo, Congresswoman and Chair, W20 Group Argentina. The session will put a spotlight on the importance of diversity and inclusion in the communications industry and more broadly in society. Other Mobile World Congress keynote sessions will explore topics including content and media, the digital economy, the Fourth Industrial Revolution, mobile operator strategies, smart services, and sustainability, among others. For more information on the Mobile World Congress conference, visit: www.mobileworldcongress.com/conference-programmes/agenda/.

Additional Exhibitors, Sponsors and Partners Confirmed for 2018

The GSMA announced several new exhibitors, sponsors and partners for Mobile World Congress. In the automotive sector, BMW Group will showcase its BMW i brand in a driverless car demonstration, while Byton will highlight its new connected car, joining other automakers including Mercedes-Benz, SEAT and Toyota on the show floor. Kazakh Telecom and Salesforce are also among the latest companies confirmed to exhibit at Mobile World Congress, joining previously announced exhibitors including Alibaba, AT&T, China Mobile, Cisco Systems, Deutsche Telekom, Ericsson, Essential, Facebook, Google, HTC, Huawei, Intel, Lenovo, LG, Microsoft, NTT DOCOMO, Nokia Solutions and Networks, Orange, Qualcomm Incorporated, SK Telecom, Telefónica, Verizon, Vivo, Vodafone, Xiaomi and ZTE, among others.

New for 2018, the GSMA has expanded the footprint of Mobile World Congress to include the South Village, located at the South Entrance of Fira Gran Via. This new outdoor hospitality and networking area serves as a vibrant welcoming point for Mobile World Congress, while offering additional meeting facilities for exhibitors and casual seating for attendees. Additionally, a second Meet & Eat venue will be located adjacent to the South Village, with food stands featuring local cuisine. For more information on the exhibition, visit www.mobileworldcongress.com/exhibition/.

New Mobile World Congress sponsors include Oath, which has signed on as a Networking Garden Sponsor alongside Android, Celtra, Citi, EY, HTC, Ogury and Visa. Verizon has joined as a Sponsor for Women4Tech Speed Coaching and Networking and Supporting Sponsor for the Women4Tech Summit, while Unilever is confirmed as a Supporting Sponsor for Women4Tech at 4YFN. For more information, visit www.mobileworldcongress.com/about/sponsors-partners/.

Innovation City 2018 to Showcase 5G, AI, Drones, IoT

In the GSMA Innovation City, visitors will experience how mobile-connected products and services are creating a better future for citizens and businesses around the world, in diverse areas such as home, automotive, health, agriculture, utilities, industrial and more. The City will feature leading-edge demonstrations of technologies including 5G, artificial intelligence, drones and the Internet of Things, among many others. Innovation City partners including Cisco IoT, Huawei, KT Corporation, Sierra Wireless and Turkcell, alongside GSMA programmes including Future Networks, Identity, Industry Purpose and Internet of Things, will showcase how mobile is positively impacting the lives of billions of people around the world. For more information, visit www.mobileworldcongress.com/exhibition/gsma-innovation-city/.

4YFN 2018: First Keynote Speakers and Mentoring Sessions

The first confirmed keynote speakers for 4YFN include Kathrin Buvac, Chief Strategy Officer at Nokia; Andrew Bolwell, Vice President and Global Head at HP Tech Ventures; Naveen Jain, Founder and CEO of Viome and Founder of Moon Express; and many others. A key element of the 2018 4YFN programme are the mentoring sessions, which are designed to help accelerate startups’ international growth and improve their relations with clients and the entrepreneurial ecosystem. Over four days, 4YFN will provide an opportunity to connect international startups, investors and large corporations in several different meetings, pitching competitions, “pitch the press” sessions and networking activities, as well as exhibition areas. For more information, visit: www.mobileworldcongress.com/experiences/4yfn/.

New Developments in Women4Tech

In addition to the Women4Tech Keynote, the Women4Tech Summit taking place on Thursday, 1 March will examine a range of topics, from equality and career development to mentoring and education, from entrepreneurship to communication. The Women4Tech Summit will feature speakers from leading companies including AT&T, Cisco, Deloitte Digital, EY, Facebook, Qualcomm, Syniverse, Telefónica, Verizon and many others. At 4YFN, Women4Tech will host a diversity panel on Tuesday, 27 February and an interactive workshop focusing on female leadership for startups on Wednesday, 28 February. For more information on Women4Tech, visit www.mobileworldcongress.com/experiences/gsma-women4tech/.

More than 30 Partner Programmes from Mobile Ecosystem Leaders

With the addition of several new Partner Programmes and Power Hour Sessions in the Hall 8.0 NEXTech Theatres, attendees now have access to more than 30 programmes developed by leading players from across the mobile ecosystem. New full-day events include the CMO Summit, GameLab Mobile, GTI, Huawei, Samsung and the Sports & Entertainment Summit 2018, while half-day sessions feature the 5GAA Automotive Association, Alibaba and Shanghai Gotell Communication Technology Holdings. New Power Hour sessions include ACI Worldwide, AppDirect, Equinix, Software AG and Xilinx. For more information on Partner Programmes, visit www.mobileworldcongress.com/conference-programmes/partner-programmes/.

Get Involved at Mobile World Congress 2018

For more information on Mobile World Congress 2018, including how to attend, exhibit or sponsor, visit www.mobileworldcongress.com. Follow developments and updates on Mobile World Congress on Twitter @GSMA using #MWC18, on our LinkedIn Mobile World Congress page www.linkedin.com/company/gsma-mobile-world-congress or on Facebook at www.facebook.com/mobileworldcongress/.

The Mobile World Congress is the cornerstone of the Mobile World Capital, which will be hosted in Barcelona through 2023. The Mobile World Capital encompasses programmes and activities that span the entire year and will benefit not only the citizens of Barcelona, Catalonia and Spain, but also the worldwide mobile industry. For more information on the Mobile World Capital, visit www.mobileworldcapital.com.

-ENDS-

About the GSMA

The GSMA represents the interests of mobile operators worldwide, uniting nearly 800 operators with more than 300 companies in the broader mobile ecosystem, including handset and device makers, software companies, equipment providers and internet companies, as well as organisations in adjacent industry sectors. The GSMA also produces industry-leading events such as Mobile World Congress, Mobile World Congress Shanghai, Mobile World Congress Americas and the Mobile 360 Series of conferences.

For more information, please visit the GSMA corporate website at www.gsma.com. Follow the GSMA on Twitter: @GSMA.

Contact information

Media Contacts:
For the GSMA
Beau Bass
+44 79 7662 4962
beau.bass@webershandwick.com
or
Pau Guerrero / Gloria Almirall
+34 93 236 09 00
PGuerrero@webershandwick.com
or
GSMA Press Office
pressoffice@gsma.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Servier and Taiho Oncology Announce Phase III LONSURF® Study Has Met Primary and Secondary Endpoints Demonstrating Prolonged Overall Survival and Progression-Free Survival in Patients with Refractory Metastatic Gastric Cancer21.10.2018 09:10Pressemelding

Servier and Taiho Oncology, Inc. (U.S.), a subsidiary of Taiho Pharmaceutical Co., Ltd. (Japan), jointly announced today clinical data from the pivotal Phase III TAS-102 Gastric Study (TAGS) evaluating LONSURF® (trifluridine/tipiracil, TAS-102) versus placebo and best supportive care in patients with heavily pre-treated metastatic gastric cancer who have progressed or are intolerant to previous lines of therapy. The study met its primary endpoint of prolonged overall survival (OS) and secondary endpoint measures of progression-free survival (PFS) consistently supported the OS results, as well as continuing to demonstrate the predictable safety and tolerability profile of trifluridine/tipiracil. Data from TAGS was presented by Dr. Hendrik-Tobias Arkenau, Executive Medical Director of the Sarah Cannon Research Institute UK and an investigator for TAGS, at the ESMO 2018 Congress in Munich, Germany during an oral session (Abstract #LBA25). The study results were simultaneously published in

Phase 3 Data on Filgotinib in Biologic-Experienced Rheumatoid Arthritis to Be Presented at 2018 ACR/ARHP Annual Meeting20.10.2018 22:30Pressemelding

Gilead Sciences, Inc. (Nasdaq: GILD) and Galapagos NV (Euronext & NASDAQ: GLPG) today announced detailed results from the Phase 3 FINCH 2 clinical trial of filgotinib, an investigational, selective JAK1 inhibitor, in adults with moderately-to-severely active rheumatoid arthritis and prior inadequate response or intolerance to biologic agents. The data, which are being presented as a late-breaking poster at the 2018 American College of Rheumatology/Association of Rheumatology Health Professionals (ACR/ARHP) Annual Meeting in Chicago, suggest filgotinib has a potential role in addressing important unmet needs in the treatment of rheumatoid arthritis. Positive efficacy data from FINCH 2 were previously announced in September 2018. The data show statistically significant improvements in the proportion of patients achieving a range of clinical efficacy endpoints, including the proportion of patients achieving American College of Rheumatology 20 percent (ACR20, primary endpoint), 50 percent

Manchester United and True Religion Launch Denim Range19.10.2018 17:37Pressemelding

Manchester United (NYSE:MANU) and luxury denim brand True Religion have collaborated to launch a range of premium club branded denim wear. A first for the club, the new global partnership with the iconic American denim brand will see a range of men’s & women’s co-branded styles go on sale beginning 26th October in the club’s Megastore as well as online via United Direct and truereligion.com & eu.truereligion.com. The exclusive collection features jeans, shirts and jackets, including a highly desirable limited edition denim jacket embroidered with the club’s crest. Fans will have the opportunity to win a selection of clothing from the new range by visiting www.manutd.com/truereligion. Manchester United’s Group Managing Director, Richard Arnold, comments: “True Religion is a well-known, established name in fashion, creating unique designs without compromising on quality. The range we have collaborated on includes the same attention to detail and craftsmanship that has made True Religion

Arch Insurance Announces Strategic Leadership Changes19.10.2018 13:10Pressemelding

Arch Insurance today announced that Matt Shulman will assume the newly created role of CEO, Arch Insurance North America, effective January 1, 2019. In this role, he will lead Arch Insurance’s operations in the United States and Canada. He will report to Nicolas Papadopoulo, Chairman and CEO of Arch Worldwide Insurance Group. Mr. Shulman, who has more than 20 years of experience in the insurance industry, has been with Arch Insurance since 2009 and has served as the President and CEO of Arch Insurance Europe since 2016. “Matt brings significant U.S. and international experience to this role. Under his leadership, together with our senior team, Arch Insurance will continue to enhance our value proposition to our customers through a robust, diversified product portfolio, creative solutions and excellent service,” Mr. Papadopoulo said. Arch Insurance has also created a new organizational structure with three Chief Underwriting Officers (CUO) dedicated to specific lines of business. These

Takeda to Present Results from Phase 3 ALTA-1L Trial Highlighting Intracranial Efficacy of ALUNBRIG® (brigatinib) Versus Crizotinib in First-Line Advanced ALK+ Non-Small Cell Lung Cancer19.10.2018 12:00Pressemelding

Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that intracranial efficacy data from the Phase 3 ALTA-1L (ALK in Lung Cancer Trial of BrigAtinib in 1 st Line) trial showed improved intracranial progression-free survival (PFS) and intracranial objective response rate (ORR) with ALUNBRIG (brigatinib) compared to crizotinib among anaplastic lymphoma kinase-positive (ALK+) non-small cell lung cancer (NSCLC) patients. Data for these secondary endpoints will be presented in a poster discussion at the European Society for Medical Oncology (ESMO) 2018 Congress on Friday, October 19 at 2:00 p.m. CET in Munich, Germany. These results further support ALUNBRIG as a potential treatment for adults with ALK+ locally advanced or metastatic NSCLC who had not received a prior ALK inhibitor. ALUNBRIG is currently not approved as first-line therapy for advanced ALK+ NSCLC. “ALK+ NSCLC often spreads to the brain, so having options that can clearly demonstrate efficacy both in the brain an

Vertex Receives European CHMP Positive Opinion for KALYDECO® (ivacaftor) to Treat Patients With Cystic Fibrosis Aged 12 to <24 months With Certain Mutations in the CFTR Gene19.10.2018 11:54Pressemelding

Vertex Pharmaceuticals (Europe) Limited today announces that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for KALYDECO® (ivacaftor) to include the treatment of people with cystic fibrosis (CF) aged 12 to <24 months who have at least one of the following nine mutations in their cystic fibrosis transmembrane conductance regulator (CFTR) gene: G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R. If the European Commission issues a favorable adoption of the EMA CHMP opinion for the extension of indication, ivacaftor will be the first and only medicine approved in Europe to treat the underlying cause of CF in patients aged 12 to <24 months, who have specific mutations in the CFTR gene. “Cystic fibrosis is a chronic, progressive disease that is present at birth, with symptoms often occurring in infancy, so early treatment is crucial to deliver the best possible outcomes for patients,” said Reshma Kewalr